Showing results (1171-1180 of 1,632) with videos related to
Sort By:
Pageof 164
Blood|May 15, 1993
Characterization of vascular permeability factor/vascular endothelial growth factor receptors on mononuclear phagocytesH Shen, M Clauss, J Ryan, et al.Journal of the American Chemical Society|March 19, 2009
Slow hydrogen atom transfer reactions of oxo- and hydroxo-vanadium compounds: the importance of intrinsic barriersChristopher R Waidmann, Xin Zhou, Erin A Tsai, et al.Journal of the American Chemical Society|June 13, 2012
Molecular orbitals of the oxocarbons (CO)n, n = 2-6. Why does (CO)4 have a triplet ground state?Xiaoguang Bao, Xin Zhou, Charity Flener Lovitt, et al.Annals of Internal Medicine|July 1, 1982
Leukocyte-derived interferon (alpha) in human breast carcinoma. The American Cancer Society phase II trialE C Borden, J F Holland, T L Dao, et al.IEEE Transactions on Ultrasonics, Ferroelectrics, and Frequency Control|October 25, 2016
Methods of Generating Submicrometer Phase-Shift Perfluorocarbon Droplets for Applications in Medical UltrasonographyPaul S Sheeran, Naomi Matsuura, Mark A Borden, et al.Journal of Immunology (Baltimore, Md. : 1950)|February 1, 1989
Amino acid substitutions in VH CDR2 change the idiotype but not the antigen-binding of monoclonal antibodies to alpha(1----6)dextransS K Sikder, P Borden, F Gruezo, et al.Biochimica Et Biophysica Acta|November 8, 1979
The isolation of bovine-heart cytochrome c oxidase subunits. Dependence on phospholipid and cholate-contentF E Verheul, J C Boonman, J W Draijer, et al.ACS Biomaterials Science & Engineering|November 5, 2024
Effect of Microbubble Size, Composition, and Multiple Sonication Points on Sterile Inflammatory Response in Focused Ultrasound-Mediated Blood-Brain Barrier OpeningPayton J Martinez, Jane J Song, Jair I Castillo, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|February 24, 2001
Meta-analysis to assess the efficacy of interferon-alpha in patients with follicular non-Hodgkin's lymphomaI E Allen, S D Ross, S P Borden, et al.Molecular Cancer Therapeutics|August 5, 2010
Tyrosine phosphatase inhibitor-3 sensitizes melanoma and colon cancer to biotherapeutics and chemotherapeuticsSuman Kundu, Keke Fan, Mingli Cao, et al.Pageof 164